Related Facts

• Effectiveness of pacemaker/defibrillators to control AFib

  Widespread use of pacemaker/defibrillators to control atrial fibrillation could result in a 50% decrease in stroke.  [ Get More Details ]

• AFib practice guidelines reduce direct health care costs

  The use of practice guidelines in atrial fibrillation (AF) patients significantly decreased hospitalization and resource utilization—with an average decrease in 30-day total direct health care costs of around $1,400 per patient.  [ Get More Details ]

• Cost-savings associated with optimal anticoagulation in AFib patients

  If half of all atrial fibrillation patients receiving suboptimal or no anticoagulation instead received optimal anticoagulation, 28,000 strokes could be prevented each year at a savings of around $2.5 billion in direct…  [ Get More Details ]

• Cost of warfarin therapy for AFib patients

  In patients with nonvalvular atrial fibrillation (AF) and one additional stroke risk factor, warfarin therapy cost $8,000 per quality-adjusted life-year (QALY) saved.  [ Get More Details ]

• t-PA cost savings

  The total annual benefit to society from t-PA use in the United States is around $363 million—$60 million in direct cost savings to society plus an additional 7,510 QALYs. This means…  [ Get More Details ]